PD-L1 expression in pancreatic ductal adenocarcinoma is a poor prognostic factor in patients with high CD8+ tumor-infiltrating lymphocytes: highly sensitive detection using phosphor-integrated dot staining

被引:0
|
作者
So Yamaki
Hiroaki Yanagimoto
Koji Tsuta
Hironori Ryota
Masanori Kon
机构
[1] Kansai Medical University Hirakata Hospital,Department of Surgery
[2] Kansai Medical University,Department of Pathology and Laboratory Medicine
关键词
Pancreatic adenocarcinoma; PD-L1; Immunohistochemistry; Phosphor-integrated dots;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:726 / 733
页数:7
相关论文
共 50 条
  • [41] Expression of PD-L1, PD-L2, and IDO1 on tumor cells and density of CD8-positive tumor-infiltrating lymphocytes in early-stage lung adenocarcinoma according to histological subtype
    Kazuki Takada
    Gouji Toyokawa
    Fumihiko Kinoshita
    Tomoko Jogo
    Kenichi Kohashi
    Sho Wakasu
    Yuki Ono
    Kensuke Tanaka
    Taro Oba
    Atsushi Osoegawa
    Tetsuzo Tagawa
    Koichi Azuma
    Isamu Okamoto
    Mototsugu Shimokawa
    Yoshinao Oda
    Masaki Mori
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 2639 - 2650
  • [42] Expression of PD-L1, PD-L2, and IDO1 on tumor cells and density of CD8-positive tumor-infiltrating lymphocytes in early-stage lung adenocarcinoma according to histological subtype
    Takada, Kazuki
    Toyokawa, Gouji
    Kinoshita, Fumihiko
    Jogo, Tomoko
    Kohashi, Kenichi
    Wakasu, Sho
    Ono, Yuki
    Tanaka, Kensuke
    Oba, Taro
    Osoegawa, Atsushi
    Tagawa, Tetsuzo
    Azuma, Koichi
    Okamoto, Isamu
    Shimokawa, Mototsugu
    Oda, Yoshinao
    Mori, Masaki
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (10) : 2639 - 2650
  • [43] Programmed Death Ligand 1 (PD-L1) Expression and CD8+ Tumor-infiltrating Lymphocyte-based Tumor Immune Microenvironment Classification in Gynecologic Carcinosarcoma: Prognostic Impact and Implications for Therapy
    Ordner, Jeffrey
    Amezcua, Jose M. Gutierrez
    Marcus, Alan
    Shukla, Pratibha S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2023, 42 (04) : 364 - 375
  • [44] Tumoral PD-L1 expression in desmoplastic melanoma is associated with depth of invasion, tumor-infiltrating CD8 cytotoxic lymphocytes and the mixed cytomorphological variant
    Frydenlund, Noah
    Leone, Dominick
    Yang, Shi
    Hoang, Mai P.
    Deng, April
    Hernandez-Perez, Marier
    Singh, Rajendra
    Biswas, Asok
    Yaar, Ron
    Mahalingam, Meera
    MODERN PATHOLOGY, 2017, 30 (03) : 357 - 369
  • [45] Expression of PD-L1 in tumor-associated nerves correlates with reduced CD8+ tumor-associated lymphocytes and poor prognosis in prostate cancer
    Mo, Ru-Jun
    Han, Zhao-Dong
    Liang, Ying-Ke
    Ye, Jian-Heng
    Wu, Shu-Lin
    Lin, Sharron X.
    Zhang, Yan-Qiong
    Song, Sheng-Da
    Jiang, Fu-Neng
    Zhong, Wei-De
    Wu, Chin-Lee
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (12) : 3099 - 3110
  • [46] Characterization of PD-L1 protein expression and CD8+ tumor-infiltrating lymphocyte density, and their associations with clinical outcome in small-cell lung cancer
    Sun, Yajun
    Zhai, Changyun
    Chen, Xiaoxia
    Dong, Zhengwei
    Hou, Likun
    Zhou, Caicun
    Jiang, Tao
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (06) : 748 - +
  • [47] Low PD-1 Expression in Cytotoxic CD8+ Tumor-Infiltrating Lymphocytes Confers an Immune-Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value
    Mazzaschi, Giulia
    Madeddu, Denise
    Falco, Angela
    Bocchialini, Giovanni
    Goldoni, Matteo
    Sogni, Francesco
    Armani, Giovanna
    Lagrasta, Costanza Annamaria
    Lorusso, Bruno
    Mangiaracina, Chiara
    Vilella, Rocchina
    Frati, Caterina
    Alfieri, Roberta
    Ampollini, Luca
    Veneziani, Michele
    Silini, Enrico Maria
    Ardizzoni, Andrea
    Urbanek, Konrad
    Aversa, Franco
    Quaini, Federico
    Tiseo, Marcello
    CLINICAL CANCER RESEARCH, 2018, 24 (02) : 407 - 419
  • [48] PD-L1 expression and tumor-infiltrating lymphocytes: Correlations and prognostic values in Chinese triple-negative breast cancer patients with different molecular subtyping
    Li, Yanping
    Ma, Jing
    Ma, Xiaoxi
    Chen, Chen
    Ruan, Miao
    Yang, Wentao
    Shui, Ruohong
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 262
  • [49] Discordance of PD-L1 expression in primary and metastatic ovarian high-grade serous carcinoma and its correlation with CD8 + tumor-infiltrating lymphocytes and patient prognosis
    Tao Zhang
    Xin Zhou
    Xiaofei Zhang
    Shuang Niu
    Hao Chen
    Feng Zhou
    Virchows Archiv, 2023, 482 : 755 - 766
  • [50] Stromal infiltrating CD8+ and CD20+ lymphocytes and CD204+ M2 macrophages but not PD-L1 expression on tumor cells are prognosticators for patients with resectable thymic carcinoma
    Sato, Jun
    Motoi, Noriko
    Kitano, Shigehisa
    Yamamoto, Noboru
    Watanabe, Shunichi
    Ohe, Yuichiro
    Hiraoka, Nobuyoshi
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35